General MedicationsORALStandard
VIGABATRIN
VIGABATRIN
Standard Dose
500MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary
Approval overview VIGABATRIN is listed in Drugs@FDA under application 215707 (ANDA).
Marketing status: Prescription Active ingredient VIGABATRIN Form and strength TABLET;ORAL - 500MG Sponsor ZYDUS LIFESCIENCES Submission history Latest submission status date: 2026-03-18 00:00:00.
Structured Monograph
Clinical summary
Approval overview VIGABATRIN is listed in Drugs@FDA under application 215707 (ANDA). Marketing status: Prescription Active ingredient VIGABATRIN Form and strength TABLET;ORAL - 500MG Sponsor ZYDUS LIFESCIENCES Submission history Latest submission status date: 2026-03-18 00:00:00. Submission type: SUPPL.
Monitoring
- • Review priority: N/A
- • Marketing status: Prescription
Interaction Notes
- No interaction notes stored yet.